CME Group Inc. $CME Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. reduced its position in CME Group Inc. (NASDAQ:CME) by 1.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 942,163 shares of the financial services provider’s stock after selling 13,568 shares during the period. Sumitomo Mitsui Trust Group Inc. owned approximately 0.26% of CME Group worth $259,679,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of CME. GQG Partners LLC raised its holdings in shares of CME Group by 7,676.3% during the 1st quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider’s stock valued at $584,975,000 after buying an additional 2,176,685 shares during the period. Wellington Management Group LLP raised its holdings in shares of CME Group by 370.5% during the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider’s stock valued at $704,068,000 after buying an additional 2,089,935 shares during the period. Nuveen LLC purchased a new stake in shares of CME Group during the 1st quarter valued at about $218,842,000. Alliancebernstein L.P. raised its holdings in shares of CME Group by 185.5% during the 1st quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider’s stock valued at $330,182,000 after buying an additional 808,740 shares during the period. Finally, Egerton Capital UK LLP raised its holdings in shares of CME Group by 79.4% during the 1st quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider’s stock valued at $459,003,000 after buying an additional 765,773 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at CME Group

In related news, Director William R. Shepard acquired 262 shares of CME Group stock in a transaction that occurred on Thursday, September 25th. The stock was acquired at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the transaction, the director directly owned 258,459 shares of the company’s stock, valued at $68,540,742.21. This trade represents a 0.10% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the transaction, the general counsel owned 7,851 shares of the company’s stock, valued at $2,056,962. This represents a 4.76% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock valued at $3,527,956 over the last 90 days. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

CME has been the topic of several analyst reports. Morgan Stanley raised their target price on CME Group from $312.00 to $314.00 and gave the company an “overweight” rating in a report on Thursday. JPMorgan Chase & Co. lifted their price objective on CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a report on Tuesday, October 14th. Keefe, Bruyette & Woods lifted their price objective on CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a report on Monday, October 13th. Citigroup upgraded CME Group from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. Finally, TD Cowen lifted their price objective on CME Group from $288.00 to $290.00 and gave the stock a “hold” rating in a report on Thursday. Eight investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, CME Group currently has a consensus rating of “Hold” and an average price target of $284.53.

CME Group Price Performance

Shares of NASDAQ CME opened at $269.54 on Friday. CME Group Inc. has a twelve month low of $213.94 and a twelve month high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $97.14 billion, a price-to-earnings ratio of 26.12, a price-to-earnings-growth ratio of 6.18 and a beta of 0.41. The business has a 50 day simple moving average of $266.47 and a 200-day simple moving average of $271.67.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The business had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the business earned $2.68 EPS. The business’s quarterly revenue was down 3.0% on a year-over-year basis. As a group, equities research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s payout ratio is 48.45%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.